Here’s the pattern I see over and over.
A company hits a growth inflection — PE money comes in, or the board starts pushing for aggressive targets — and suddenly everyone’s talking about “GTM transformation.” New hires. New tech stack. A 100-day plan with a lot of slides and not a lot of infrastructure.
Then execution breaks.
Not because the strategy was wrong. Because the GTM system never evolved past founder-led, siloed, and ad hoc. The company was running on tribal knowledge and heroic individual contributors, and the moment you try to scale that, it collapses under its own weight.
This isn’t a hot take. It’s thermodynamics. You cannot push enterprise-grade growth targets through a system built for a 30-person company where the CEO still closes deals from their cell phone.
The Six Dysfunctions Hiding in Plain Sight
The founder-to-system gap. Most portfolio companies are still running on whatever the founding team figured out in year two. There’s no codified ICP. No documented plays. No real handoff process. Just a handful of people who “know how it works” — and a growing team that doesn’t.
Siloed GTM. Sales, marketing, CS, and product are each operating from different definitions of success, different data, and different ideas about who the customer is. They’re not a revenue engine. They’re four departments who happen to share a Slack workspace.
Fuzzy ICP and positioning. The company is chasing too many segments, hasn’t pressure-tested its positioning against the current competitive set, and can’t articulate why a buyer should choose them in language that buyer actually uses. This gets exponentially worse when the mandate is to move upmarket or into new regions.
Hero-seller dependency. The transition from “three people who are really good at selling this” to a predictable, repeatable sales motion is where most scaling efforts quietly die. You’ll see it in the numbers before anyone admits it: win rates dropping into the mid-teens, cycles stretching, pipeline coverage below 3x.
Marketing as a service bureau. Marketing is measured on lead volume instead of pipeline contribution. It operates as a cost center fulfilling sales requests instead of a strategic GTM function. This single dysfunction caps NRR, constrains valuation, and burns out every CMO who walks through the door.
CS as an afterthought. Customer success is reactive. There’s no expansion playbook, no health scoring, no real integration with the GTM motion. Expansion and cross-sell are “on the roadmap” — meaning nobody owns them.
If you’re a PE operating partner or a portfolio CMO reading this list and wincing, you’re not alone. You’re the rule.
What Actually Fixes This
I’m going to be direct: there is no shortcut here. You can’t dashboard your way out of a system that doesn’t exist. But you can build the system — and you can build it fast if you’re disciplined about what matters.
Anchor GTM to the investment thesis.
This sounds obvious. It almost never happens. The investment thesis says “expand into mid-market healthcare,” and somehow the 100-day plan is a collection of disconnected marketing campaigns and a new CRM implementation.
Translate the thesis into explicit GTM objectives: which segments, what motions (land vs. expand), what mix of new vs. expansion ARR, and on what timeline. Then make those objectives the backbone of every priority across sales, marketing, and CS. If a project doesn’t trace back to how the deal creates value, kill it.
Get ruthless on ICP and positioning.
Define a sharp ICP at the account, buyer, and problem level — firmographic, technographic, trigger-based — and kill the segments that don’t match the thesis or the unit economics. This is the part that requires spine. Everyone has a “strategic” account they don’t want to let go of.
Then rebuild positioning as category + problem + differentiated approach + proof, tuned specifically to that ICP and the current competitive landscape. Document all of it in a single GTM blueprint that every revenue team member can find: ICP, key use cases, buying committee map, core messages, and — critically — disqualification criteria. If you can’t define who you’re not for, you haven’t done the work.
Design one revenue system, not four department plans.
Map the full funnel from target account to renewal and expansion. Clear stages. Clear entry and exit criteria. Clear owners across marketing, SDR, sales, and CS.
Standardize definitions. If sales calls something an MQL and marketing calls it something else and CS has never heard the term, you don’t have a funnel. You have a vocabulary problem masquerading as a pipeline problem.
Then build one GTM operating rhythm: weekly pipeline reviews, monthly funnel diagnostics, quarterly strategy reviews — with all revenue functions in the room. Not a monthly readout from each silo. One conversation about one system.
Industrialize the sales motion.
Codify winning deals into repeatable plays. For each segment and use case, define sequences, qualification criteria, proof assets, and mutual action plans. Put in basic sales architecture: territories, coverage model, role clarity, forecasting methodology.
Enablement becomes a core function, not a content library nobody uses. Training and coaching aligned to actual plays, measured on win rate, ramp time, and deal velocity — not completion certificates.
Upgrade marketing from “leads” to growth lever.
Shift accountability from volume metrics to pipeline contribution, CAC payback, and conversion within target segments tied to the thesis. Focus investment where GTM is actually bottlenecked: category awareness and credibility for earlier-stage portfolios, ABM and expansion enablement for more mature ones.
Tighten the lead lifecycle with shared scoring, SLAs on follow-up, and monthly feedback loops that refine targeting and messaging. If sales and marketing are still fighting about MQL quality, you haven’t built the system. You’ve just given both sides new ammunition.
Make CS and expansion a first-class GTM function.
Treat net revenue retention as a primary GTM metric, not a dashboard tile nobody looks at. Design actual plays for onboarding, adoption, renewal, and expansion — the same way you’d design plays for acquisition.
Define who owns expansion quota. Build account planning into the CS motion. Stand up basic infrastructure — health scoring, QBRs, success plans — early, before churn forces your hand.
The Board-Level Gut Check
If you’re a PE operating partner, a portfolio CEO, or a CMO trying to figure out where the gaps are, here’s the checklist that actually matters:
Is GTM explicitly tied to the investment thesis and the 100-day plan? If not, you’re funding random growth projects, not value creation.
Do you have a documented, sharp ICP and segment focus?If not, you’re diluting resources and confusing your own positioning.
Is there one shared revenue funnel with common definitions and KPIs? If not, every team is optimizing for their own scoreboard.
Are sales plays, territories, and roles codified and coached? If not, you’re scaling on hope, not repeatability.
Is marketing measured on pipeline and payback — not just leads? If not, you’re spending money without connecting it to value creation.
Is CS integrated into GTM with explicit NRR targets and plays? If not, you’re leaving valuation on the table while overspending on acquisition.
More than two “no” answers means the GTM system has gaps that no amount of strategy will paper over. The strategy already exists. What’s missing is the operational infrastructure to make it run.
That’s fixable — but only if someone actually builds it instead of drawing it on a whiteboard.